Molecular Matrix, Inc.

We founded Molecular Matrix in 2011. After seven years of rigorous research and development on our tissue regeneration technology, we received FDA clearance for our breakthrough bone regeneration medical device. We believe that medicine is a continuous quest to ensure that people receive the life saving or life-enhancing treatments they need to return to full life. Our mission is to create those treatments and provide them worldwide. We are dedicated to developing an innovative platform technology for tissue regeneration applications. Osteopoietic Systems™ is our first clinical solution to the need for value-driven and safe bone regeneration products.